Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical study of RUCONEST comparison with a competitor product for the treatment of acute attacks of hereditary angioedema

Trial Profile

A clinical study of RUCONEST comparison with a competitor product for the treatment of acute attacks of hereditary angioedema

Recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Aug 2018

At a glance

  • Drugs Conestat alfa (Primary)
  • Indications Hereditary angioedema
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Aug 2018 New trial record
    • 25 Jul 2018 According to a media release, patient recruitment in this study is expected to be completed in Q3. The top-line data is expected in Q4 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top